X4 Pharmaceuticals, Inc. Common Stock (XFOR) is a publicly traded Healthcare sector company. As of October 1, 2026, XFOR trades at $2.83 with a market cap of $287.53M and a P/E ratio of -15.18. XFOR moved -2.76% today. Year to date, XFOR is -27.25%; over the trailing twelve months it is -21.82%. Its 52-week range spans $1.35 to $16.29. Analyst consensus is strong buy with an average price target of $11.00. Rallies surfaces XFOR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
XFOR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XFOR recently traded at $2.83. Market cap is $287.53M. P/E ratio is -15.18. Revenue is $2.56M.
| Metric | Value |
|---|---|
| Price | $2.83 |
| Market Cap | $287.53M |
| P/E Ratio | -15.18 |
| EPS | $-0.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.29 |
| 52-Week Low | $1.35 |
| Volume | 431.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.56M |
| Net Income | $-37.45M |
| Gross Margin | 68.83% |
3 analysts cover XFOR: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.00.